The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer.
<h4>Purpose</h4>To examine the in vitro and in vivo efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type colorectal cancer (CRC).<h4>Experimental design</h4>PIK3CA mutant and wild-type human CRC cell lines were treated in vitro with NVP-BEZ235, and the resulting effec...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2011-01-01
|
| シリーズ: | PLoS ONE |
| オンライン・アクセス: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025132&type=printable |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
